— Know what they know.
Not Investment Advice

AKAN NASDAQ

Akanda Corp.
1W: -35.1% 1M: -47.1% 3M: -83.7% YTD: -79.9% 1Y: -97.1% 3Y: -99.9%
$1.98
-0.23 (-10.41%)
 
Weekly Expected Move ±14.2%
$1 $2 $2 $2 $3
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 29 · $64085 mcap · 32174 float · 3225.93% daily turnover · Short 37% of daily vol

Cash Flow Trends

Operating Cash Flow
-$4M -165.3% ▼
Capital Expenditures
$2M -139589.6% ▼
5Y CAGR: +25.1%
Free Cash Flow
-$6M -304.7% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$4M +2414.6% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$2M-$8M-$12M-$32M-$4M
Depreciation & Amort.$249K$309K$4M$4M$141K
Stock-Based Comp.$0$0$559K$0$0
Change in Working Capital$30K-$587K$2M$3M-$950K
Other Non-Cash Items$669K$2M-$6M$23M$925K
Operating Cash Flow-$1M-$7M-$11M-$2M-$4M
— Investing Activities —
Capital Expenditures-$439K-$576K-$311K-$2K-$2M
Acquisitions (Net)$0$0-$3M$0$1M
Investment Purchases$0$0-$801K$0$0
Investment Sales$0$0$740K$0$0
Other Investing$7K$0-$740K$26K-$367K
Investing Cash Flow-$432K-$576K-$4M$25K-$1M
— Financing Activities —
Net Debt Issuance$1M$6M-$794K-$84K-$340K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$2M-$1M
Financing Cash Flow$1M$11M$14M$1M$9M
Net Change in Cash-$806K$3M-$3M-$162K$4M
Cash End of Period$14K$3M$256K$94K$4M
Free Cash Flow-$2M-$7M-$12M-$2M-$6M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms